Nemucore Medical Innovations Overview
- Year Founded
-
2008

- Status
-
Private
- Employees
-
6

- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$92.3K
- Investors
-
3
Nemucore Medical Innovations General Information
Description
Operator of a clinical development company intended to offer molecularly-targeted nanomedicines. The company's clinical development services include the development and commercialization of NMI-900 a life-saving molecularly-targeted therapeutic which is an aurora B Kinase inhibitor that evades cancer defenses and delivers medications that can treat tumors, enabling cancer patients to treat newly diagnosed, recurrent, and multi-drug resistant cancers.
Contact Information
Website
www.nemucore.comCorporate Office
- One Hollis Street
- Suite 232
- Wellesley, MA 02482
- United States
Corporate Office
- One Hollis Street
- Suite 232
- Wellesley, MA 02482
- United States
Nemucore Medical Innovations Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Equity Crowdfunding | 30-Apr-2018 | $92.3K | Completed | Generating Revenue | ||
7. Grant | 31-Jan-2016 | Completed | Generating Revenue | |||
6. Later Stage VC (Series A) | 07-Dec-2015 | Completed | Generating Revenue | |||
5. Grant | 31-Jul-2015 | Completed | Generating Revenue | |||
4. Grant | 01-Jan-2013 | Completed | Generating Revenue | |||
3. Grant | 31-Aug-2012 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 10-Apr-2012 | Completed | Generating Revenue | |||
1. Grant | 01-Jan-2010 | $302K | Completed | Generating Revenue |
Nemucore Medical Innovations Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Nemucore Medical Innovations Patents
Nemucore Medical Innovations Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220218831-A1 | Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand | Inactive | 01-May-2019 | ||
CA-3138517-A1 | Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand | Pending | 01-May-2019 | ||
EP-3962480-A1 | Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand | Inactive | 01-May-2019 | ||
EP-3962480-A4 | Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand | Inactive | 01-May-2019 | ||
US-20170275319-A1 | Platinum derivatives for hydrophobic formulations | Inactive | 25-Jul-2013 | C07F15/0093 |
Nemucore Medical Innovations Signals
Nemucore Medical Innovations Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Boynton Angels | Angel Group | Minority | ||
Massachusetts Biomedical Initiatives | Accelerator/Incubator | |||
U.S. Department of Health and Human Services | Government |
Nemucore Medical Innovations FAQs
-
When was Nemucore Medical Innovations founded?
Nemucore Medical Innovations was founded in 2008.
-
Where is Nemucore Medical Innovations headquartered?
Nemucore Medical Innovations is headquartered in Wellesley, MA.
-
What is the size of Nemucore Medical Innovations?
Nemucore Medical Innovations has 6 total employees.
-
What industry is Nemucore Medical Innovations in?
Nemucore Medical Innovations’s primary industry is Drug Discovery.
-
Is Nemucore Medical Innovations a private or public company?
Nemucore Medical Innovations is a Private company.
-
What is Nemucore Medical Innovations’s current revenue?
The current revenue for Nemucore Medical Innovations is
. -
How much funding has Nemucore Medical Innovations raised over time?
Nemucore Medical Innovations has raised $1.09M.
-
Who are Nemucore Medical Innovations’s investors?
Boynton Angels, Massachusetts Biomedical Initiatives, and U.S. Department of Health and Human Services have invested in Nemucore Medical Innovations.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »